Prostate cancer Board decisions

The Veteran's prostate cancer residuals are rated at 60 percent effective November 14, 2019. The rating for erectile dysfunction remains noncompensable.

The Board denied service connection for various conditions, including lumbar spine disability, right and left lower extremity frostbite residuals, psychiatric disorder (including PTSD), prostate cancer, cervical spine disability, shoulder, elbow, and wrist disabilities, and gastrointestinal disorders. The claims were not reopened due to lack of new and material evidence.

The Veteran's prostate cancer is not related to service, and the Board denied his claim for service connection based on direct evidence.

The Board has remanded the claims for cerebellar ataxia, prostate cancer, kidney stones, gastroesophageal reflux disease (GERD), hypertension, and obstructive sleep apnea due to outstanding VA treatment records that need to be obtained.

The Board has remanded the claims for left and right eye disabilities other than exotropia, as well as hemorrhoids. The Veteran's eye conditions are being evaluated further to determine their etiology, and a medical opinion is needed regarding the relationship of his hemorrhoids to service-connected prostate cancer.

The Board has denied service connection for left knee disability, prostate cancer, and respiratory disability due to lack of evidence linking these conditions to the Veteran's active duty service.

The Veteran's claim for special monthly compensation based on the need for aid and attendance or housebound status was denied because his service-connected disabilities do not meet the criteria, including due to lack of permanent housebound status.

The Veteran's claim for service connection for prostate cancer was received on June 1, 1993. The effective date of the grant of service connection is set at June 1, 1993 due to a May 2014 rating decision based on the Nehmer class action. An earlier effective date prior to June 1, 1993 for accrued benefits purposes was denied.

The Board has decided to remand the cases of prostate cancer and erectile dysfunction for additional medical opinions. The Veteran's prostate cancer is related to his in-service gonococcal infection, but a VA opinion is needed to clarify this relationship. For erectile dysfunction, the connection to service needs further clarification as it may be secondary to prostate cancer.

The Board has granted service connection for chronic fatigue as a result of the Veteran's service-connected bladder and prostate cancers, Type II diabetes mellitus, and bilateral lower extremity peripheral neuropathy.

The Veteran's appeal for service connection for metastatic prostate cancer has been dismissed due to his death.

The Veteran's service connection claims for coronary artery disease (CAD)/ischemic heart disease and prostate cancer have been denied as there is no evidence of herbicide exposure or continuity of symptoms after service.

The Veteran's prostate cancer and diabetes mellitus are granted service connection due to presumed exposure to herbicide agents during his nautical service in the offshore eligible waters as defined by the Blue Water Navy Vietnam Veterans Act of 2019.

The Veteran's prostate disorder, including prostatitis and prostate cancer, was not incurred in service. The Board found that the evidence did not support direct or presumptive service connection.

The Veteran's claims for service connection for prostate cancer and coronary artery disease (CAD) are granted due to presumed exposure to herbicide agents during his time stationed at Nakhon Phanom RTAFB in Thailand. The Board found the Veteran's testimony regarding his time spent near the base perimeter credible, establishing facts-found exposure to herbicide agents.

The Board has decided to remand the case due to insufficient evidence regarding the Veteran's alleged exposure to herbicide agents and whether he entered the territorial waters of the Republic of Vietnam. The AOJ is tasked with verifying these details.

The Veteran's residuals of prostate cancer, which were rated at 100% prior to February 1, 2014, are now rated at 60%. The rating is effective from February 1, 2014, and continues until the Veteran's death on March 9, 2018.

The Board has denied the claim for service connection for the cause of death due to prostate cancer, finding that there is no evidence linking the Veteran's in-service leg injury and amputation to his death from prostate cancer.

The Veteran's appeal of the issues related to prostate cancer, coronary artery disease, skin disability, hypertension, gastritis and irritable bowel syndrome, hemorrhoids, and depressive disorder has been remanded for further development.,An effective date prior to October 6, 2014 for the grant of service connection for tinnitus is also being remanded.

The Veteran's prostate cancer and bladder cancer are presumed to be due to herbicide exposure, and the Board has granted service connection for these conditions. The respiratory disability is remanded for further evaluation.